Skip to main content

Frühbehandlung der leichten Hypertonie

  • Chapter
  • 32 Accesses

Zusammenfassung

Geringgradige Blutdruckerhöhungen werden relativ häufig und in allen Altersgruppen beobachtet. Eine einheitlich anerkannte Definition der sog. leichten Hypertonie fehlt, ebenso wie die Beantwortung der Frage, bis zu welchem Blutdruckwert eine Behandlung nicht erforderlich ist. Theoretisch müßte die Entscheidung zur Therapie durch die Höhe desjenigen Blutdruckwertes bestimmt werden, der das Risiko einer sog. Exzeßmorbidität und -mortalität zu einem zukünftigen Zeitpunkt in sich birgt.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Alameda County Blood Pressure Study (1968) State of California, Department of Public Health, Berkeley

    Google Scholar 

  2. Ames RP, Hill P (1976) Increase in serum-lipids during treatment of hypertension with chlorthalidone. Lancet 1: 721–723

    Article  PubMed  CAS  Google Scholar 

  3. Davidson C, Thadani U, Singleton W, Taylor SH (1976) Comparison of beta-blocking drugs during chronic treatment. Brit Med J 3: 7–9

    Article  Google Scholar 

  4. Day JL, Simpson N, Metcalfe J et al. (1979) Metabolic consequences of atenolol and propranolol in treatment of essential hypertension. Brit med J 1: 77–80

    Article  PubMed  CAS  Google Scholar 

  5. Dyer AR, Stamler J, Shekelle R, Schoenberger JA, Farinaro E (1977) Hypertension in the elderly. Med Clin North America 61: 513–529

    CAS  Google Scholar 

  6. Freis ED (1976) Salt, volume and the prevention of hypertension. Circulation 53: 589–595

    Article  PubMed  CAS  Google Scholar 

  7. Gluck Z, Weidmann P, Mordasini R et al. (1979) Einfluß einer Diuretikatherapie auf die Serumlipoproteine: Ein unerwünschter Effekt? Schweiz med Wschr 109: 104–108

    PubMed  CAS  Google Scholar 

  8. Goldman AI, Steele BW, Schnaper HW et al. (1980) Serum lipoprotein levels during chlorthalidone therapy. J Amer med Ass 244: 1691–1695

    Article  CAS  Google Scholar 

  9. Grimm RH, Leon AS, Hunninghake DB, Lenz K, Hannan P, Blackburn H (1981) Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. Ann Intern Med 94: 7–12

    PubMed  Google Scholar 

  10. Hansson L, Werkö H (1977) Beta-adrenergic blockade in hypertension. Amer Heart J 93: 394–404

    Article  PubMed  CAS  Google Scholar 

  11. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. (1979) JAMA 242: 2562–71

    Google Scholar 

  12. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. II. Mortality by race, sex, and age. (1979) JAMA 242: 2572–77

    Google Scholar 

  13. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. III. Reduction in stroke incidence among persons with high blood pressure. (1982) JAMA 247: 633–38

    Google Scholar 

  14. Hypertension Detection and Follow-up Program Cooperative Group. The effect of treatment on mortality in „mild“ hypertension. Results of the Hypertension Detection and Follow-up Program. (1982) New Engl J Med 307: 976–980

    Google Scholar 

  15. Kaplan NM (1981) Whom to treat: The dilemma of mild hypertension. Amer Heart J 101: 867–870

    Article  PubMed  CAS  Google Scholar 

  16. Joos C, Kewitz H, Reinhold-Kourniati D (1980) Effects of diuretics on plasma lipoproteins in healthy men. Eur J Clin Pharmaco117: 251–257

    Google Scholar 

  17. Julius S (1977) Borderline hypertension. An Overview. Med Clin North America 61: 495–510

    CAS  Google Scholar 

  18. Kannel WB, Schwartz MJ, McNamara PM (1969) Blood pressure and risk of coronary heart disease: The Framingham study. Dis Chest 56: 43–52

    Google Scholar 

  19. Kokubu T, Itoh I, Kurita H, Coni T, Murata K, Yuba I (1982) Effect of prazosin on serum lipids. J Cardiovasc Pharmacol 4: 228–232

    Article  Google Scholar 

  20. Leren P, Helgeland A, Holme J, Foss OP, Hjermann J, Lund-Larsen PG (1980) Effect of propranolol and prazosin on blood lipids. The Oslo Study. Lancet 2: 4–6

    Google Scholar 

  21. Leren P, Foss OP, Helgeland A et al. (1981) Effects of pindolol and hydrochlorothiazide on blood lipids. The Oslo Study. Clin Trials J 18: 254–261

    Google Scholar 

  22. Levy RL, White PD, Stroud WD et al. (1945) Transient tachycardia: Prognostic significance alone and in association with transient hypertension. JAMA 129: 585–588

    Google Scholar 

  23. MacGregor GA, Markandu ND, Smith SJ, Banks RA, Sagnella GA (1982) Moderate potassium supplementation in essential hypertension. Lancet 2: 567–570

    Article  PubMed  CAS  Google Scholar 

  24. MacKenzie LF, Shepherd P (1937) The significance of past hypertension in applicants later presenting normal average blood pressures. Proc Ass Life Insur Med Dir Amer 24: 157–178

    Google Scholar 

  25. Mathisen HS, Loken H, Brox D et al. (1965) The prognosis in essential hypertension. Scand J Clin Lab Invest 17: 257–261

    Article  PubMed  Google Scholar 

  26. Metropolitan Life Insurance Company: Blood pressure: Insurance experience and its implications. (1961) Metropolitan Life Insurance Co., New York

    Google Scholar 

  27. Morgan T, Gillies A, Morgan G, Adam W, Wilson M, Carney S (1978) Hypertension treated by salt restriction. Lancet 1: 227–230

    Article  PubMed  CAS  Google Scholar 

  28. National High Blood Pressure Education Program. Report of Task Force 1 - Data Base. (1973) DHEW Publication No (NIH) 74–593

    Google Scholar 

  29. Overlack A, Stumpe KO (1978) Antihypertensiver Effekt einer fixen Beta-RezeptorenblockerDiuretikum-Kombination bei täglich einmaliger Applikation. Med Welt 29: 1517–1520

    PubMed  CAS  Google Scholar 

  30. Priddle W, Liu S, Breithaupt D et al. (1968) Amelioration of high blood pressure in the elderly. J Amer Ger Soc 16: 887–892

    CAS  Google Scholar 

  31. Reisin E, Abei R, Modan M, Silverberg DS, Elia-hou H, Modan B (1978) Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. New Engl J Med 298: 1–6

    Article  PubMed  CAS  Google Scholar 

  32. Shanks RG (1976) The properties of beta-adrenoceptor antagonists. Postgrad med J 52: 14–20

    Article  PubMed  Google Scholar 

  33. Stamler J, Lindberg HA, Berkson DM et al. (1958) Epidemiological analysis of hypertension and hypertensive disease in the labor force of a Chicago utility company. Proc Counc High Blood Press Res 7: 23–52

    Google Scholar 

  34. Stamler J, Berkson DM, Dyer A et al. (1975) Relationship of multiple variables to blood pressure. In: Paul O (ed) Epidemiology and Control of Hypertension. Symposia Specialists Miami, p 307

    Google Scholar 

  35. Stumpe KO, Kolloch RE (1977) Beta-blocking agents in the treatment of hypertension. Compreh Ther3: 55–65

    Google Scholar 

  36. Stumpe KO, Krück F (1982) Beta-adrenerge Rezeptorenblocker oder Diuretika zur Langzeittherapie der arteriellen Hypertension? DMW 107: 363–365

    Article  CAS  Google Scholar 

  37. Stumpe KO, Kolloch RE, Vetter H et al. (1976) Acute and long-term studies of the mechanism of action of beta-blocking drugs in lowering blood pressure. Amer J Med 60: 853–865

    Article  PubMed  CAS  Google Scholar 

  38. Tanaka N, Sakaguchi S, Oshige K et al. (1976) Effect of chronic administration of propranolol on lipoprotein composition. Metabolism 25: 1071–1075

    Article  PubMed  CAS  Google Scholar 

  39. The Management Committee: The Australian therapeutic trial in mild hypertension. (1980) Lancet 1: 1261–1267

    Google Scholar 

  40. Thomas CB, Ross DC, Higgenbottom CQ (1964) Precursors of hypertension and coronary disease among healthy medical students. Discriminant function analysis II using parental history as the criterion Bull Johns Hopkins Hosp 115: 245

    CAS  Google Scholar 

  41. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension. II: Results in patients with diastolic blood pressures averaging 90 through 114 mmHg. (1970)JAMA 213: 1143–1152

    Google Scholar 

  42. Waal-Manning HJ (1976) Hypertension: Which criterion. beta-blocker? Drugs 12: 412–441

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stumpe, K.O. (1984). Frühbehandlung der leichten Hypertonie. In: Rosenthal, J. (eds) Arterielle Hypertonie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-00760-0_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-00760-0_32

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-00761-7

  • Online ISBN: 978-3-662-00760-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics